We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-6.3%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$563M
AUM Growth
-$77.2M
Cap. Flow
+$3.41M
Cap. Flow %
0.61%
Top 10 Hldgs %
62.51%
Holding
124
New
20
Increased
17
Reduced
10
Closed
12
Avg Time Held
1.1 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
GPGI icon
GPGI Inc
GPGI
+$11M
2
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$10.8M
3
BC icon
Brunswick
BC
+$5.76M
4
TV icon
Televisa
TV
+$5.18M
5
DUOT icon
Duos Technologies
DUOT
+$4.54M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$32.8M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.66M
3
IHC
Independence Holding Company
IHC
+$3.1M
4
EPD icon
Enterprise Products Partners
EPD
+$2.77M
5
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
+$2.76M

Sector Composition

Rank Sector Weight
1 Healthcare 19.74%
2 Miscellaneous 15.57%
3 Industrials 15.14%
4 Financials 14.94%
5 Materials 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$85.8M 15.23%
475,000
– –
2019 Q4
9 quarters
LIN icon
2
Linde
LIN
$229B
$61.5M 10.92%
192,627
– –
2019 Q4
9 quarters
BC icon
3
Brunswick
BC
$4.19B
$50.6M 8.97%
625,000
+62,500
+11% +$5.76M
2020 Q1
8 quarters
INVE icon
4
INVE Technologies, Inc. Common Stock
INVE
$55.3M
$38.6M 6.85%
2,387,936
+191,547
+9% +$3.68M
2019 Q4
9 quarters
IVAC icon
5
DELISTED
Intevac Inc
IVAC
$26.5M 4.7%
4,949,355
– –
2019 Q4
9 quarters
PACX
6
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$20.8M 3.7%
2,125,000
– –
2021 Q2
3 quarters
CTIC
7
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$18M 3.2%
3,859,707
+3,609,707
+1,444% +$10.8M
2021 Q4
1 quarter
DRRX icon
8
DELISTED
DURECT Corp
DRRX
$17.7M 3.14%
2,641,466
– –
2019 Q4
9 quarters
SPGI icon
9
S&P Global
SPGI
$123B
$16.4M 2.91%
40,000
– –
2019 Q4
9 quarters
MDXH icon
10
MDxHealth
MDXH
$57.8M
$16.3M 2.88%
1,958,333
– –
2021 Q4
1 quarter
MRNS icon
11
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$12.4M 2.19%
1,322,463
+259,963
+24% +$2.58M
2020 Q1
8 quarters
CORS
12
DELISTED
Corsair Partnering Corporation
CORS
$12.1M 2.15%
1,250,000
– –
2021 Q3
2 quarters
TV icon
13
Televisa
TV
$1.28B
$11.7M 2.08%
1,000,000
+500,000
+100% +$5.18M
2021 Q2
3 quarters
GPGI icon
14
GPGI Inc
GPGI
$3.59B
$11.2M 1.99%
+1,776,008
New +$11M
2022 Q1
0 quarters
LSXMK icon
15
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$10.8M 1.92%
305,187
– –
2019 Q4
9 quarters
BX icon
16
Blackstone
BX
$84.6B
$10.2M 1.8%
80,000
– –
2019 Q4
9 quarters
ISLE
17
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$9.9M 1.76%
1,000,000
– –
2021 Q1
4 quarters
TCDA
18
DELISTED
Tricida, Inc. Common Stock
TCDA
$9.85M 1.75%
1,198,400
-168,953
-12% -$1.53M
2021 Q3
2 quarters
OPTN icon
19
DELISTED
OptiNose
OPTN
$9.24M 1.64%
249,479
+1,466
+0.6% +$52.3K
2021 Q4
1 quarter
THO icon
20
Thor Industries
THO
$3.62B
$9.03M 1.6%
114,753
+5,000
+5% +$460K
2020 Q1
8 quarters
DUOT icon
21
Duos Technologies
DUOT
$166M
$7.06M 1.25%
1,283,162
+829,546
+183% +$4.54M
2020 Q1
8 quarters
HLTH icon
22
DELISTED
Cue Health Inc. Common Stock
HLTH
$6.45M 1.14%
1,000,000
– –
2021 Q3
2 quarters
LIQT icon
23
LiqTech
LIQT
$11.9M
$5.29M 0.94%
270,119
-1,875
-0.7% -$81.4K
2020 Q1
8 quarters
IDN icon
24
Intellicheck
IDN
$45.6M
$5.29M 0.94%
2,073,583
– –
2019 Q4
9 quarters
BRFH icon
25
Barfresh Food Group
BRFH
$11M
$4.97M 0.88%
+725,288
New +$4.26M
2022 Q1
0 quarters
1
2 3 4 5

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2022 Portfolio in Review

As of Q1 2022, Bleichroeder LP held 124 positions worth $563M, down 12% from $641M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP's Q1 2022 filing shows 20 new, 17 increased, 10 reduced and 12 closed positions. Its largest new stake was GPGI Inc: 1,776,008 shares worth $11.2M. The largest sale was Royalty Pharma, an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.

  • Bleichroeder LP's largest Q1 2022 buy was GPGI Inc: 1,776,008 shares worth $11.2M.
  • Bleichroeder LP added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2022, an estimated $10.8M increase.
  • Bleichroeder LP's biggest Q1 2022 reduction was Tricida, Inc. Common Stock, cutting an estimated $1.53M.
  • Bleichroeder LP fully exited Royalty Pharma in Q1 2022, selling an estimated $32.8M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $563M portfolio in Q1 2022.
  • Bleichroeder LP opened 20 new positions and closed 12 in Q1 2022.
  • Bleichroeder LP's portfolio value fell 12% quarter-over-quarter to $563M.

Based on Bleichroeder LP's 13F filing for Q1 2022, filed 11 May 2022.